Metabolic engineering approaches for improved production of Concanamycin A in Streptomyces – UROP Spring Symposium 2023

Metabolic engineering approaches for improved production of Concanamycin A in Streptomyces

Linnea Verhey-Henke

Linnea Verhey-Henke photo

Pronouns: she/her

Research Mentor(s): Filipa Barroso Pereira
Research Mentor School/College/Department: Life Sciences Institute, University of Michigan / Other
Program: UROP
Session: Session 3 (11:00am – 11:50am)
Authors: Linnea Verhey-Henke, Filipa Barroso Pereira, Morgan McCauley, David H. Sherman

Abstract

Natural products are an invaluable source of pharmaceutical compounds. Traditional bioactivity-guided isolation of natural products was able to successfully identify Concanamycin A as a modulator of MHC-1 regulation in HIV-infected cells. Although this is excellent news, it comes at a price. The molecule costs >$695/mg making it unattainable for further chemical modification studies and production into a cost-effective drug. Concanamycin A is naturally produced by Streptomyces at low titters. This project focuses on the improved production of Concanamycin A through metabolic engineering and growth optimisation. First, we overexpress key pathway regulators in a known Concanamycin A producer strain. Next, by screening multiple growth conditions we were able to produce the target metabolite at concentrations of 500mg/L. Optimizing extraction and purification protocols we are now able to isolate & < 93mg/L of pure Concanamycin A. Using the developed approaches, we aim to accelerate the discovery and production of novel compounds, in sufficient quantities to support medicinal chemistry studies.

Environmental Sci

lsa logoum logo